Please ensure Javascript is enabled for purposes of website accessibility

Dividend Aristocrat Johnson & Johnson Declares Fresh Dividend; Yield Is 2.7%

By Eric Volkman – Jul 20, 2020 at 6:41PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The company is keeping its payout steady, despite declines in headline fundamentals in its Q2.

In keeping with a very long-standing habit, Johnson & Johnson's (JNJ 0.21%) board has declared a new quarterly common stock dividend. The durable healthcare and consumer goods company announced Monday that it will pay $1.01 per share on Sept. 8. Stockholders of record as of Aug. 25 will be eligible for the distribution.

On Monday's closing share price, the dividend yields 2.7%.

The word dividends ink stamped onto a sheet of paper under a pencil and a paper clip.

Image source: Getty Images.

That amount matches the previous payout; prior to that, Johnson & Johnson had disbursed $0.95 per share. Raises are par for the course for the company, which is a Dividend Aristocrat -- one of a clutch of S&P 500 components that have not only paid regular distributions, but raised them at least once annually for a minimum of 25 years in a row. The company has one of the longest raise streaks going, at 58 years.

Ever a strong cash flow generator, Johnson & Johnson hasn't necessarily been a high flyer in terms of other fundamentals lately. Both its healthcare and consumer goods products were affected by the economic downturns caused by the coronavirus pandemic, as reflected in the second-quarter results it released last Thursday. Total sales dropped by nearly 11% on a year-over-year basis, while per-share net profit saw an almost 35% decline.

Still, despite that, the company remains a favorite among dividend stock investors, not least because that yield is relatively generous. On Monday, following the announcement of the new payout, Johnson & Johnson's shares rose marginally by just under 0.2%, trailing the gains of the top equity indexes on the day.

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool recommends Johnson & Johnson. The Motley Fool has a disclosure policy.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.